Developments
Michael Rawlins: playing fair on treatments
Trusts that do not allow drugs approved by NICE to be prescribed are breaking the law
Posted in: Developments
Strike out Stroke
Urgent coordinated action is needed to avoid the thousands of preventable strokes that leave many atrial fibrillation (AF) patients mentally and physically disabled or dead, every year.
Posted in: Developments
Patients capable of self-monitoring their anticoagulation therapy
Patients capable of self-monitoring their warfarin therapy could benefit from a one-third reduction in death from all causes, according to a meta-analysis in this week's issue of The Lancet.
Posted in: Developments
Dabigatran has received a licence for the prevention of deep vein thrombosis and pulmonary embolism after hip and knee surgery
Study shows dabigatran etexilate, a new oral anticoagulant, is effective and safe in preventing thromboembolic disease after orthopaedic surgery.
Posted in: Developments
Expert pharmacists get the go ahead
Pharmacists with Special Interests (PhwSIs) are to offer care and advice about diabetes, and long-term conditions on patients doorsteps.
Posted in: Developments
New guidelines for atrial fibrillation
New guidelines aim to increase the identification and treatment of atrial fibrillation (AF) a 'hidden disease' that is the commonest sustained cardiac rhythm disorder.
Posted in: Developments
Front Line in Stroke Prevention - Report
The Front Line Report was commissioned to look at the current status of anticoagulation treatment in the UK and to identify key issues that anticoagulation clinics and the patients who attend these clinics face.
Posted in: Developments
Venous thromboembolism CMO press release
Every hospital patient should have their own risk assessment for VTE that will improve patient safety and help save thousands of lives each year, says an expert working group whose report was launched by the Chief Medical Officer (CMO) today.
Posted in: Developments
NICE guidance on Venous Thromboembolism (VTE)
NICE has now issued its guidance on the prevention of venous thromboembolism for surgical patients.
Posted in: Developments
European Medicines Agency recommends approval of dabigatran etexilate
European Medicines Agency recommends approval of novel oral anticoagulant, dabigatran etexilate (Pradaxa®)
Posted in: Developments